has been cited by the following article(s):
|
[1]
|
In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase …
|
|
Rubaye, AAR Mahmood, LH Tahtamouni… - Results in …,
2024 |
|
|
|
|
[2]
|
3d Pharamacophore Model, Virtual Screening, Binding Affinity and Molecular Dynamics Studies of Potential Anticancerous Compounds Against Mammalian Target …
|
|
2023 |
|
|
|
|
[3]
|
Novel 5-bromoindole-2-carboxylic acid derivatives as EGFR inhibitors: synthesis, docking study, and structure activity relationship
|
|
Anti-Cancer Agents in …,
2023 |
|
|
|
|
[4]
|
Novel and Latest Computational and Development of Anticancer Cancer
|
|
Onco Therapeutics,
2022 |
|
|
|
|
[5]
|
Results in Chemistry
|
|
Rubaye, AAR Mahmood
|
|
|
|
|
[1]
|
In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors
Results in Chemistry,
2024
DOI:10.1016/j.rechem.2024.101329
|
|
|
|
|
[2]
|
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis,
Docking Study, and Structure Activity Relationship
Anti-Cancer Agents in Medicinal Chemistry,
2023
DOI:10.2174/1871520623666230227153449
|
|
|
|
|
[3]
|
Novel and Latest Computational and Development of Anticancer Cancer
Onco Therapeutics,
2022
DOI:10.1615/OncoTherap.2022044866
|
|
|
|
|
[4]
|
Novel and Latest Computational and Development of Anticancer Cancer
Onco Therapeutics,
2022
DOI:10.1615/OncoTherap.2022044866
|
|
|
|